New

ETF model portfolios designed for real investor needs. Discover →

Advertisement

BBHvsBMEDETF Comparison

ETF 1
BBH

VanEck Biotech ETF

This fund is part of
US Health Care
-3.06%
VS
ETF 2
BMED

iShares Health Innovation Active ETF

This fund is part of
Healthcare Technology
-0.55%

VanEck Biotech ETF (BBH) belongs to the US Health Care segment. iShares Health Innovation Active ETF (BMED) is part of the Healthcare Technology segment. BBH's top 1 sector exposures are Healthcare. In contrast, BMED's top sector exposures are Healthcare and Non-Corporate. BBH is less expensive with a Total Expense Ratio (TER) of 0.35%, versus 0.77% for BMED. BBH is up 32.7% year-to-date (YTD) with +$22M in YTD flows. BMED performs worse with 19.29% YTD performance, and +$5M in YTD flows. Run a side-by-side ETF comparison of BBH and BMED below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

BBH vs BMED performance and flow charts

Performance

-2.00.02.04.06.08.0%Oct 5Oct 12Oct 19Oct 26Nov 2

Cumulative Flows

05,000,00010,000,00015,000,000Oct 5Oct 12Oct 19Oct 26Nov 2

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 11/05/2026
1M3MYTD1Y3Y5Y
Perf.
BBH
BMED
+4.37%+4.77%
+19.27%+14.92%
+32.70%+19.29%
+38.73%+27.84%
+68.11%+67.06%
+34.27%+20.48%
Flows
BBH
BMED
+$15M-
+$29M+$1M
+$22M+$5M
+$24M+$6M
-$123M+$7M
-$126M+$6M
Volatility and drawdown
3M1Y3Y5Y
Volatility
BBH
BMED
+29.42%+23.37%
+22.89%+18.56%
+20.65%+17.00%
+21.87%+18.28%
Max drawdown
BBH
BMED
-6.32%-5.85%
-10.54%-14.71%
-22.78%-19.76%
-33.06%-31.66%
Max drawdown duration
BBH
BMED
36d31d
150d196d
440d237d
1456d1474d
Trading data

Create an account to view trading data

Join for free
BBH
BMED
Last sale
11/5/2026 at 2:30 PM
$251.01
$36.03
Previous close
11/04/2026
$261.63
$37.30
Consolidated volume
11/04/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of October 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

BMED
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
BBH
BMED
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 11/5/2026 at 2:30 PM
Live
Closed
BBH
BMED
Last price
$251.01
$36.03
1D performance
-4.06%
-3.42%
AuM$518.81 M$14.41 M
E/R0.35%0.77%
Characteristics
BBH
BMED
Management strategyPassiveActive
ProviderVanEckiShares
BenchmarkMVIS US Listed Biotech 25 Index-
N° of holdings2553
Asset classEquities-
Trailing 12m distribution yield
Join
Join
Inception dateDecember 20, 2011September 29, 2020
ESGNoNo
Advertisement
Exposure

Countries

BBH
USA
88.89%
Other
11.11%
BMED
USA
86.39%
Other
13.61%

Sectors

BBH
Healthcare
100%
Other
-0%
BMED
Healthcare
97.84%
Other
2.16%
Advertisement

Diversification

BBH

Total weight of top 15 holdings out of 15

85.93%
BMED

Total weight of top 15 holdings out of 15

57.51%

Top 15 holdings

Data as of September 30, 2026
BBH
Amgen, Inc.
15.74%
Gilead Sciences, Inc.
13.28%
Vertex Pharmaceuticals, Inc.
8.21%
Regeneron Pharmaceuticals, Inc.
6.38%
Moderna, Inc.
6.35%
Natera, Inc.
5.31%
argenx SE
4.62%
IQVIA Holdings, Inc.
4.43%
Revolution Medicines, Inc.
4.17%
Illumina, Inc.
3.99%
Guardant Health, Inc.
2.97%
Alnylam Pharmaceuticals, Inc.
2.76%
BeOne Medicines Ltd.
2.74%
Biogen, Inc.
2.73%
Incyte Corp.
2.24%
BMED
Moderna, Inc.
5.19%
Danaher Corp.
5.19%
Gilead Sciences, Inc.
5.00%
AbbVie, Inc.
4.61%
Thermo Fisher Scientific, Inc.
4.41%
Johnson & Johnson
4.17%
IQVIA Holdings, Inc.
3.75%
Waters Corp.
3.66%
Biogen, Inc.
3.52%
Vertex Pharmaceuticals, Inc.
3.35%
Mettler-Toledo International, Inc.
3.33%
Merck & Co., Inc.
3.10%
Edwards Lifesciences Corp.
2.96%
Illumina, Inc.
2.70%
Roche Holding AG
2.58%
Frequently asked questions about BBH and BMED

How have the BBH and BMED ETFs performed in 2026?

As of November 5, 2026, BBH is up 32.7% year-to-date (YTD), while BMED has returned 19.29%. That puts BBH better performer ahead so far this year.

Which ETF is attracting more investor money: BBH or BMED?

Year-to-date, the BBH ETF saw +$22M in flows, compared to +$5M for BMED.

Which ETF is more volatile: BBH or BMED?

Over the past year, BBH had a volatility of 22.89%, while BMED experienced 18.56%.

Which ETF is bigger: BBH or BMED?

As of November 5, 2026, BBH holds $518.81 M in assets under management (AUM), while BMED manages $14.41 M.

What sectors do the BBH and BMED ETFs invest in?

BBH leans toward sectors like Healthcare. Meanwhile, BMED focuses on Healthcare.

What are the top holdings of the BBH ETF and BMED ETF?

BBH top holdings include Amgen, Inc., Gilead Sciences, Inc. and Vertex Pharmaceuticals, Inc.. BMED holds in its top three: Moderna, Inc., Danaher Corp. and Gilead Sciences, Inc..

Which ETF is more diversified: BBH or BMED?

BBH holds 25 securities with 85.93% of its assets in the top 15. BMED has 55 securities and a top 15 weight of 57.51%.

Advertisement
Advertisement
New Report

ETFs’ Next Act: From Access to Selection

Global ETF Survey 2026